Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced the closing of a registered direct offering with accredited investors for ...

Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialized life sciences company dedicated to the research and development of therapeutics for ...

Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901. A replay of the call will also be available on the ...

J.P. Morgan, Leerink Partners and Guggenheim Securities are acting as joint book-running managers for the offering. LifeSci Capital is also acting as lead manager for the offering.

ISTANBUL, July 08, 2025 (GLOBE NEWSWIRE) -- LivMedCell has officially launched a groundbreaking research collaboration with ...

Chicago-based physician announces expansion of charitable programs focused on healthcare access and community wellness ...

The U.S. pilot study, now underway at Johns Hopkins, builds on the strong early data from Australia. Combined insights from ...

Transforming Healthcare Ltd, a leader in healthcare consultancy and innovation, has announced the global launch of the Healthcare Convergence Framework® (HCF), the world’s first AI/Robotics Readiness ...

About PhenQ PhenQ is a multi-action fat burning supplement available over the counter, backed by clinical studies and endorsed by more than 800 medical practitioners. It is designed to support women ...

BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with ...

Dr. Patel’s decision to partner with Heald signals a growing recognition that the future of chronic disease care lies not in more apps or prescriptions, but in empowering people with data, support, ...

ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with renal and inflammatory ...